Law No.11/2021 on Pharmaceutical Activity in the Field of Traditional Chinese Medicines and the Registration of Proprietary Chinese Medicines

Previously notified in N3MAC25
Law No. 11/2021 stipulates that unless exempted by law, the import, export and wholesale activities of proprietary Chinese medicines, toxic Chinese medicinal materials or general Chinese medicinal materials included in the "List of Chinese Medicinal Materials Adopted in the Macao SAR", and their prepared portions or extracts shall be subject to licensing. It also stipulates that all proprietary Chinese medicines must first be registered with the Pharmaceutical Administration Bureau before they can be circulated in the Macao SAR.